Showing results (1-10 of 160) with videos related to
Sort By:
Pageof 16
Expert Review of Vaccines|March 8, 2008
Plasmodium falciparum malaria vaccines in developmentJohan Vekemans, W Ripley BallouMicrobes and Infection|April 7, 2007
Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccineW Ripley BallouMalaria Journal|January 1, 2010
Immunological mechanisms underlying protection mediated by RTS,S: a review of the available dataVasee S Moorthy, W Ripley BallouThe American Journal of Tropical Medicine and Hygiene|January 31, 2008
Two decades of commitment to malaria vaccine development: GlaxoSmithKline BiologicalsW Ripley Ballou, Conor P CahillMalaria Journal|August 6, 2011
Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in AfricaAmanda Leach, Johan Vekemans, Marc Lievens, et al.Frontiers in Immunology|June 8, 2017
Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical TrialRobert A van den Berg, Margherita Coccia, W Ripley Ballou, et al.The Journal of Infectious Diseases|February 25, 2003
Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C.1W Ripley Ballou, Jennifer L Reed, William Noble, et al.Plos One|November 17, 2010
Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trialPedro Aide, John J Aponte, Montse Renom, et al.Plos One|October 28, 2009
A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in GabonBertrand Lell, Selidji Agnandji, Isabelle von Glasenapp, et al.Pageof 16